PMID- 20498130
OWN - NLM
STAT- MEDLINE
DCOM- 20101026
LR  - 20240109
IS  - 1552-695X (Electronic)
IS  - 1534-7354 (Linking)
VI  - 9
IP  - 2
DP  - 2010 Jun
TI  - Integrative tumor board: a case report and discussion from East-West Cancer 
      Center.
PG  - 236-45
LID - 10.1177/1534735410371479 [doi]
AB  - AIM: To introduce the application of wheel balance cancer therapy (WBCT) in 
      cancer treatment through an intensive study of a representative patient. METHOD: 
      A 59-year-old, female patient who was a secondhand smoker and who carried no 
      significant medical and family history was diagnosed with T1N0M1 (stage 4) lung 
      adenocarcinoma. Immunohistochemistry was positive for thyroid transcription 
      factor-1, CK7, cyclin D1, p53, and Ki-67 on both lung biopsy specimens. An open 
      lobectomy with mediastinal nodal dissection followed. The patient was transferred 
      to East-West Cancer Center (EWCC) suffering from exertional dyspnea (NYHA [New 
      York Heart Association] grade 2) with thoracic pain and pain in both upper limbs 
      because of the decreased ventilatory capacity and reduced exercise capacity after 
      a pulmonary resection. She also complained of emotional stress. EWCC provided 
      WBCT, a multimodality alternative protocol based on the theory of traditional 
      oriental medicine. Physicians regularly monitored whether metastasis or 
      recurrence existed through blood and radiation tests. Observations and dialogues 
      with the patient were used to record the changes in symptoms such as thoracic 
      pain, dyspnea, anxiety, and fear. RESULTS: Treatments at EWCC led to a 
      disease-free survival of 28 months without adjuvant chemotherapy. Neither 
      metastasis nor recurrence occurred during this period. Exertional dyspnea 
      recovered to NYHA grade 1. Other physical and psychological symptoms were 
      alleviated. CONCLUSION: This report suggests that WBCT may have the potential for 
      extending life expectancy, controlling symptoms, and improving quality of life in 
      cancer patients.
FAU - Park, Hyo-Min
AU  - Park HM
AD  - East-West Cancer Center, Dunsan Oriental Medical Hospital of Daejeon University, 
      Daejeon, Republic of Korea.
FAU - Kim, Seo-Yeon
AU  - Kim SY
FAU - Jung, In-Chul
AU  - Jung IC
FAU - Lee, Yeon-Weol
AU  - Lee YW
FAU - Cho, Chong-Kwan
AU  - Cho CK
FAU - Yoo, Hwa-Seung
AU  - Yoo HS
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20100524
PL  - United States
TA  - Integr Cancer Ther
JT  - Integrative cancer therapies
JID - 101128834
SB  - IM
MH  - Adenocarcinoma/pathology/*therapy
MH  - Cancer Care Facilities
MH  - Complementary Therapies/*methods
MH  - Delivery of Health Care, Integrated/methods
MH  - Disease-Free Survival
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Lung Neoplasms/pathology/*therapy
MH  - Medicine, Korean Traditional
MH  - Middle Aged
MH  - Neoplasm Staging
MH  - Quality of Life
EDAT- 2010/05/26 06:00
MHDA- 2010/10/27 06:00
CRDT- 2010/05/26 06:00
PHST- 2010/05/26 06:00 [entrez]
PHST- 2010/05/26 06:00 [pubmed]
PHST- 2010/10/27 06:00 [medline]
AID - 1534735410371479 [pii]
AID - 10.1177/1534735410371479 [doi]
PST - ppublish
SO  - Integr Cancer Ther. 2010 Jun;9(2):236-45. doi: 10.1177/1534735410371479. Epub 
      2010 May 24.